Notch1 expression is upregulated in glioma and is associated with tumor progression

被引:35
作者
Jiang, Ligang [1 ]
Wu, Jie [1 ]
Chen, Qiuhui [1 ]
Hu, Xinyu [1 ]
Li, Wei [2 ]
Hu, Guohua [1 ]
机构
[1] Jilin Univ, Hosp 2, Dept Neuromed, Changchun 130041, Jilin Province, Peoples R China
[2] Beihua Univ, Subsidiary Hosp, Dept Neuromed, Jilin, Jilin Province, Peoples R China
关键词
Glioma; Notch1; Progression; PHOTODYNAMIC THERAPY; CLASSIFICATION;
D O I
10.1016/j.jocn.2010.07.131
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Notch signaling plays a complex role in human malignancies. It can affect cell proliferation, differentiation and apoptosis either positively or negatively, depending on cell type. In the present study we measured the expression of Notch1 in clinical glioma specimens and investigated a possible association between Notch1 expression and World Health Organization grade. Ninety-eight gliomas plus adjacent normal tissue and 26 specimens of normal control tissue were collected, and expression of Notch1 mRNA and protein were assessed using quantitative real-time polymerase chain reaction, western blot and immunohistochemical analysis. We found that Notch1 mRNA and protein were expressed at higher levels in gliomas than in the adjacent tissue or in control brain tissue (p < 0.05). Moreover, expression of Notch1 was closely associated with glioma progression, since expression levels increased from grade I to grade IV disease (p < 0.05). Notch1 expression was also significantly associated with Karnofsky performance scale (KPS) score: Notch1 expression was significantly higher in patients with a lower KPS score (p < 0.05). These findings confirm that Notch1 expression is upregulated in glioma and suggest it is related to tumor progression. If Notch1 plays an important oncogenic role in glioma progression, it may be a potential diagnostic and therapeutic target. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:387 / 390
页数:4
相关论文
共 19 条
[1]   Notch signaling: Cell fate control and signal integration in development [J].
Artavanis-Tsakonas, S ;
Rand, MD ;
Lake, RJ .
SCIENCE, 1999, 284 (5415) :770-776
[2]   Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines [J].
Bigas, A ;
Martin, DIK ;
Milner, LA .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (04) :2324-2333
[3]  
Jang MS, 2000, CURR OPIN MOL THER, V2, P55
[4]  
Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI [10.3322/caac.20006, 10.3322/caac.21387]
[5]   THE NEW WHO CLASSIFICATION OF BRAIN-TUMORS [J].
KLEIHUES, P ;
BURGER, PC ;
SCHEITHAUER, BW .
BRAIN PATHOLOGY, 1993, 3 (03) :255-268
[6]   Prognosis of glioma patients by combined immunostaining for survivin, Ki-67 and epidermal growth factor receptor [J].
Kogiku, Minoru ;
Ohsawa, Ikuroh ;
Matsumoto, Koushi ;
Sugisaki, Yuichi ;
Takahashi, Hiroshi ;
Teramoto, Akira ;
Ohta, Shigeo .
JOURNAL OF CLINICAL NEUROSCIENCE, 2008, 15 (11) :1198-1203
[7]   The 2007 WHO classification of tumours of the central nervous system (vol 114, pg 97, 2007) [J].
Louis, David N. ;
Ohgaki, Hiroko ;
Wiestler, Otmar D. ;
Cavenee, Webster K. ;
Burger, Peter C. ;
Jouvet, Anne ;
Scheithauer, Bernd W. ;
Kleihues, Paul .
ACTA NEUROPATHOLOGICA, 2007, 114 (05) :547-547
[8]   Notch1 functions as a tumor suppressor in mouse skin [J].
Nicolas, M ;
Wolfer, A ;
Raj, K ;
Kummer, JA ;
Mill, P ;
van Noort, M ;
Hui, CC ;
Clevers, H ;
Dotto, GP ;
Radtke, F .
NATURE GENETICS, 2003, 33 (03) :416-421
[9]   Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation [J].
Purow, BW ;
Haque, RM ;
Noel, MW ;
Su, Q ;
Burdick, MJ ;
Lee, J ;
Sundaresan, T ;
Pastorino, S ;
Park, JK ;
Mikolaenko, I ;
Maric, D ;
Eberhart, CG ;
Fine, HA .
CANCER RESEARCH, 2005, 65 (06) :2353-2363
[10]   Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems [J].
Rhodes, A ;
Jasani, B ;
Barnes, DM ;
Bobrow, LG ;
Miller, KD .
JOURNAL OF CLINICAL PATHOLOGY, 2000, 53 (02) :125-130